<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>North Bay Business Journal &#187; LEAD Therapeutics</title>
	<atom:link href="http://www.northbaybusinessjournal.com/tag/lead-therapeutics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.northbaybusinessjournal.com</link>
	<description></description>
	<lastBuildDate>Thu, 09 Feb 2012 02:43:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>BioMarin acquires LEAD Therapeutics</title>
		<link>http://www.northbaybusinessjournal.com/18093/biomarin-acquires-lead-therapeutics/</link>
		<comments>http://www.northbaybusinessjournal.com/18093/biomarin-acquires-lead-therapeutics/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 21:54:05 +0000</pubDate>
		<dc:creator>Business Journal Staff Report</dc:creator>
				<category><![CDATA[Breaking News]]></category>
		<category><![CDATA[Health Care and Senior Living]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Top News Stories]]></category>
		<category><![CDATA[BioMarin Pharmaceutical]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[LEAD Therapeutics]]></category>
		<category><![CDATA[Marin County]]></category>
		<category><![CDATA[mergers and acquisitions]]></category>
		<category><![CDATA[Novato]]></category>

		<guid isPermaLink="false">http://www.northbaybusinessjournal.com/?p=18093</guid>
		<description><![CDATA[NOVATO -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said it plans to acquire LEAD Therapeutics Inc. of San Bruno in a stock deal worth $18 million up front and up to $97 million as the drug is submitted for government review and later released.

]]></description>
		<wfw:commentRss>http://www.northbaybusinessjournal.com/18093/biomarin-acquires-lead-therapeutics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

